Crossmark

Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa

Crossref DOI link: https://doi.org/10.1016/j.abd.2023.07.002

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kelmann, Samantha Vernaschi http://orcid.org/0000-0001-5963-7362
Stephan, Bruno de Oliveira http://orcid.org/0000-0002-7423-0090
Barbosa, Silvia Maria de Macedo http://orcid.org/0000-0003-2082-9521
Polastrini, Rita Tiziana Verardo http://orcid.org/0000-0002-1862-3084
Oliveira, Zilda Najjar Prado de http://orcid.org/0000-0002-8596-1999
Rivitti-Machado, Maria Cecília http://orcid.org/0000-0003-2910-7330
Spolador, Gustavo Marquezani http://orcid.org/0000-0002-8141-6985
Honjo, Rachel Sayuri http://orcid.org/0000-0002-9223-7341
Saida, Ken http://orcid.org/0000-0002-4686-6147
Matsumoto, Naomichi http://orcid.org/0000-0001-9846-6500
Kim, Chong Ae http://orcid.org/0000-0002-1754-1300
Funding

Funding for this research was provided by:

Takeda Science Foundation

Japan Agency for Medical Research and Development (JP22ek0109486, JP22ek0109493, JP22ek0109549)

Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/21644-0)

CNPq
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-01-27
More Information

This article is maintained by: Elsevier

Article Title: Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2023.07.002

Content Type: article

Copyright: © 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below